PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
29110023-2	2018	This changed at the end of 2016 when obeticholic acid was licensed in Europe for PBC patients not responding to UDCA.	obeticholic acid	37-53	dihydrolipoamide S-acetyltransferase	Homo sapiens	81-84	
29761165-5	2018	Recently, the U.S. Food and Drug Administration approved obeticholic acid to be used in certain patients with PBC.	obeticholic acid	57-73	dihydrolipoamide S-acetyltransferase	Homo sapiens	110-113